Attached files

file filename
10-K - ANNUAL REPORT - Adamis Pharmaceuticals Corpadamis-10k_0713.htm
EX-21 - SUBSIDIARIES OF ADAMIS - Adamis Pharmaceuticals Corpex-21.htm
EX-32.2 - 906 CERTIFICATION OF CFO - Adamis Pharmaceuticals Corpex-32_2.htm
EX-31.1 - 302 CERTIFICATION OF CEO - Adamis Pharmaceuticals Corpex-31_1.htm
EX-31.2 - 302 CERTIFICATION OF CFO - Adamis Pharmaceuticals Corpex-31_2.htm
EX-10.31 - STOCK ACQUISITION AGREEMENT - Adamis Pharmaceuticals Corpex-10_31.htm




EXHIBIT 32.1

CERTIFICATION OF CHIEF EXECUTIVE OFFICER

PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT

The undersigned, Dennis J. Carlo, the Chief Executive Officer of Adamis Pharmaceuticals Corporation (the “Company”), pursuant to 18 U.S.C.  1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, hereby certifies that, to the best of my knowledge:

   
 
      (1) the Company’s Annual Report on Form 10-K for the year ended March 31, 2010 (the “Report”) fully complies with the requirements of Section 13(a) of the Securities Exchange Act of 1934; and
   
 
      (2) the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

   
 
/s/ DENNIS J. CARLO
 
Dennis J. Carlo
 
Chief Executive Officer
 

Dated: July 14, 2010 

This certification is being furnished to the SEC with this Report on Form 10-K pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 and shall not, except to the extent required by such Act, be deemed filed by the Company for purposes of Section 18 of the Securities Exchange Act of 1934.